Since MMP9 is well known as a negative prognostic indicator (Kupferman et al, 2000), the association of low MMP9 with high p-ERK1 levels fits to our result that high ERK activity is associated with long recurrence-free survival times in breast cancer, although it is no proof of a causal relationship between both factors. This evidence concerns the gene MMP9 and breast carcinoma.